In women aged 65 and older, doing strength training and taking essential amino acids twice daily for 12 weeks leads to greater muscle growth and a more favorable balance of muscle-building signals compared to either approach alone, helping to slow age-related muscle decline.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether combining resistance exercise and essential amino acid supplementation consistently produces greater muscle mass and follistatin/myostatin ratio improvements across diverse populations of older women, accounting for dosage, duration, and baseline health status.
A systematic review and meta-analysis of all randomized controlled trials in women aged 65+ comparing resistance exercise plus essential amino acids (≥10g/day) versus resistance exercise alone, amino acids alone, or control, measuring skeletal muscle mass via DXA and serum follistatin/myostatin ratio as primary outcomes, with minimum 12-week duration and standardized protocols.
Whether the combination of resistance exercise and essential amino acids directly causes greater muscle hypertrophy and anabolic signaling in older women compared to single interventions, under controlled conditions.
A double-blind, placebo-controlled RCT with 200+ healthy women aged 65–75, randomized to: (1) resistance training + 11g EAA/day, (2) resistance training + placebo, (3) EAA + placebo exercise, (4) placebo control; all groups undergo supervised 3x/week resistance training for 24 weeks; primary outcomes: skeletal muscle mass via DXA, follistatin/myostatin ratio via ELISA, and muscle biopsy for mTOR pathway activation.
Whether long-term adherence to resistance exercise and essential amino acid supplementation predicts sustained improvements in muscle mass and follistatin/myostatin ratio over 2–5 years in older women.
A prospective cohort study following 500 healthy women aged 65+ for 5 years, tracking adherence to resistance training (≥2x/week) and daily EAA intake (≥10g), with annual DXA scans and serum biomarker measurements to assess changes in muscle mass and follistatin/myostatin ratio.
Whether women who maintain high follistatin/myostatin ratios and muscle mass at age 75 are more likely to have previously engaged in combined resistance training and EAA supplementation compared to those with significant muscle loss.
A case-control study comparing 100 women aged 75+ with preserved muscle mass (DXA >25kg) to 100 with sarcopenia (DXA <20kg), retrospectively assessing their 10-year history of resistance training frequency and EAA supplementation use, adjusting for baseline BMI, activity, and comorbidities.
Whether current users of resistance training and EAA supplementation have higher follistatin/myostatin ratios and muscle mass than non-users at a single point in time.
A cross-sectional survey of 1000 women aged 65–80 measuring current resistance training frequency, EAA supplement use, and muscle mass via BIA, along with serum follistatin and myostatin levels to assess associations.